Picture biomindz Mainz Biomed LSE Colorectal Cancer Screening 650x100px

Product › Details

TandAb bispecific antibody

	Next higher product group	antibody cancer drug
	Status	2012-03-05 development existent
	Organisation	Affimed Therapeutics AG
	Today	Affimed GmbH
	Group	Affimed (Group)

Record changed: 2023-07-10

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for antibody cancer drug

[1] Ipsen S.A.. (12/3/24). "Press Release: Ipsen and Biomunex Announce Exclusive Global Licensing Agreement for First-in-Class MAIT Cell Engager in Immuno-oncology". Paris....
[2] BioNTech SE. (11/13/24). "Press Release: BioNTech to Acquire Biotheus to Boost Oncology Strategy". Mainz....
[3] Ottimo Pharma Ltd.. (10/28/24). "Press Release: Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 20...
[4] Dren Bio, Inc.. (7/24/24). "Press Release: Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer". Foster City, CA....
[5] Catalym GmbH. (7/16/24). "Press Release: Catalym Announces New Financing of $150M to Support Broad Phase 2b Development Program for Visugromab". Munich....
[6] Apeiron Biologics AG. (7/8/24). "Press Release: Apeiron Biologics to Be Acquired by Ligand Pharmaceuticals for USD 100 Million". Vienna....
[7] Tacalyx GmbH. (6/11/24). "Press Release: Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs". Berlin....
[8] Biogen Inc.. (5/22/24). "Press Release: Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences". Cambridge, MA & South San Francisco, CA....
[9] Jeito Capital. (5/22/24). "Press Release: Jeito Capital Announces Acquisition of Portfolio Company HI-Bio by Biogen Inc. (Nasdaq: BIIB) for up to $1.8 Billion". Paris....
[10] StromaCare. (2/13/24). "Press Release: StromaCare Appoints Georges Rawadi as CEO". Lyon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]